| payload |
{"created_at":"2026-04-11T15:08:00.060 {"created_at":"2026-04-11T15:08:00.060011+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/beam-therapeutics-ceo-sold-over-30000-company-shares-heres-what-means-investors","value":{"fp":"0bc494516a33911c","kind":"unusual_volume","published_at":"2026-04-11T13:40:03+00:00","source":"Nasdaq Markets","summary":"Key PointsCEO John Evans sold 30,078 company shares for a transaction value of ~$739,000 on April 1, 2026.","tickers":[],"title":"Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors.","url":"https://www.nasdaq.com/articles/beam-therapeutics-ceo-sold-over-30000-company-shares-heres-what-means-investors"}}... |